jiangsu hengrui medicine c-a
(600276:Shanghai Stock Exchange)
Li Xiao Juan
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Ms. Li Xiao Juan has been Manager for Investment Planning Department and Audit Manager at China Pharmaceutical Industry Co., Ltd. since April 2006. Ms. Juan previously served as Deputy Chief of Strategy Coordination Department of Topsun Group from April 2003 to February 2005, Manager and Audit Manager of Finance and Asset Management Department of China Pharmaceutical Industry Co., Ltd. from February 2005 to April 2006. Ms. Juan served as a Director of Jiangsu Hengrui ...
Lianyungang Eco & Tech Development ZonePhone: --
Lianyungang, Jiangsu Province 222047
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.